All-trans retinoic acid and interferon-α increase CD38 expression on adult T-cell leukemia cells and sensitize them to T cells bearing anti-CD38 chimeric antigen receptors-Reference-Cited by-同舟云学术

All-trans retinoic acid and interferon-α increase CD38 expression on adult T-cell leukemia cells and sensitize them to T cells bearing anti-CD38 chimeric antigen receptors

Published:2016-05 Issue:5 Volume:6 Page:e421-e421
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Mihara K,Yoshida T,Ishida S,Takei Y,Kitanaka A,Shimoda K,Morishita K,Takihara Y,Ichinohe T

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201630.pdf

Reference15 articles.

1. Tsukasaki K, Tobinai K . Biology and treatment of HTLV-1 associated T-cell lymphomas. Best Pract Res Clin Haematol 2013; 26: 3–14.

2. Utsunomiya A, Miyazaki Y, Takatsuka Y, Hanada S, Uozumi K, Yashiki S et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 15–20.

3. Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR et al. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med 2013; 368: 1509–1518.

4. Brentjens RJ, Davila ML, Riviere I, Park J, Wang X, Cowell LG et al. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med 2013; 5: 177ra–38.

5. Kochenderfer JN, Dudley ME, Feldman SA, Wilson WH, Spaner DE, Maric I et al. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells. Blood 2012; 119: 2709–2720.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional multiomics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma;Blood Neoplasia;2024-09

2. CAR T-Cells in Acute Lymphoblastic Leukemia: Current Status and Future Prospects;Biomedicines;2023-10-02

3. Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review;Medical Oncology;2023-09-09

4. Can CD34+CD38− lymphoblasts, as likely leukemia stem cells, be a prognostic factor in B-cell precursor acute lymphoblastic leukemia in children?;Frontiers in Pediatrics;2023-08-22

5. In the Pipeline—Emerging Therapy for ALL;Pathogenesis and Treatment of Leukemia;2023